Interferon Signature in Anti-CTLA-4 and Anti-PD-1/PD-L1-Treated Cancer Patients Compared With Systemic Autoimmune Disease Patients
Conditions: Immune-Related Adverse Events; Lupus Erythematosus, Systemic; Sjogren Syndrome; Systemic Sclerosis (SSc); Inflammatory Myopathies; Solid Tumors Interventions: Drug: Immune Checkpoint […]
